The American Journal of Medicine
Volume 121, Issue 5 , Pages 433-443.e4, May 2008

Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis

  • Isabelle Peytremann-Bridevaux, MD, MPH, DSc

      Affiliations

    • Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
    • Corresponding Author InformationRequests for reprints should be addressed to Isabelle Peytremann-Bridevaux, MD, MPH, DSc, Institute of Social and Preventive Medicine, 17 Bugnon, CH-1005 Lausanne, Switzerland.
  • ,
  • Philippe Staeger, MD, MPH

      Affiliations

    • Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland
  • ,
  • Pierre-Olivier Bridevaux, MD, MSc

      Affiliations

    • Division of Pulmonary Care, Department of Medicine, University Hospitals of Geneva, Geneva, Switzerland
  • ,
  • William A. Ghali, MD, MPH

      Affiliations

    • Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Canada
  • ,
  • Bernard Burnand, MD, MPH

      Affiliations

    • Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
    • Groupe de Recherche en Gestion Thérapeutique, Faculté de Médecine, Université de Montréal, Canada.

Abstract 

Background

Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs.

Methods

We conducted a computerized search of MEDLINE, EMBASE, CINAHL, PsychINFO, and the Cochrane Library (CENTRAL) for studies evaluating interventions meeting our operational definition of disease management: patient education, 2 or more different intervention components, 2 or more health care professionals actively involved in patients' care, and intervention lasting 12 months or more. Programs conducted in hospital only and those targeting patients receiving palliative care were excluded. Two reviewers evaluated 12,749 titles and fully reviewed 139 articles; among these, data from 13 studies were included and extracted. Clinical outcomes considered were all-cause mortality, lung function, exercise capacity (walking distance), health-related quality of life, symptoms, COPD exacerbations, and health care use. A meta-analysis of exercise capacity and all-cause mortality was performed using random-effects models.

Results

The studies included were 9 randomized controlled trials, 1 controlled trial, and 3 uncontrolled before–after trials. Results indicate that the disease-management programs studied significantly improved exercise capacity (32.2 m, 95% confidence interval [CI], 4.1-60.3), decreased risk of hospitalization, and moderately improved health-related quality of life. All-cause mortality did not differ between groups (pooled odds ratio 0.84, 95% CI, 0.54-1.40).

Conclusion

COPD disease-management programs modestly improved exercise capacity, health-related quality of life, and hospital admissions, but not all-cause mortality. Future studies should explore the specific elements or characteristics of these programs that bring the greatest benefit.

Keywords: Chronic obstructive pulmonary disease, Disease management, Effectiveness, Meta-analysis, Systematic review, Quality of care

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Isabelle Peytremann-Bridevaux is supported by a grant from the Bourse de la commission pour la promotion académique des femmes, faculté de biologie et médecine de l'université de Lausanne.

PII: S0002-9343(08)00177-0

doi:10.1016/j.amjmed.2008.02.009

The American Journal of Medicine
Volume 121, Issue 5 , Pages 433-443.e4, May 2008